What is it about?
Evidence based review of edaravone; used for formulary reviews by health plans and hospitals
Featured Image
Why is it important?
Designed for formulary committees
Perspectives
Potential use drug for selected patients with ALS
Danial Baker
Washington State University
Read the Original
This page is a summary of: Formulary Drug Review: Edaravone, Hospital Pharmacy, October 2017, SAGE Publications,
DOI: 10.1177/0018578717734877.
You can read the full text:
Contributors
The following have contributed to this page
